Connect
MJA
MJA

Evidence-based policies for the control of influenza

Heath A Kelly and Nicholas Kelley
Med J Aust 2013; 198 (7): 349-350. || doi: 10.5694/mja13.10294
Published online: 15 April 2013

Influenza vaccines can prevent serious outcomes of infection, but vaccine policies should be based on the best contemporary evidence

In this issue of the Journal, two studies draw attention to potential difficulties in protecting vulnerable people from influenza infection. In the first study, Wiley and colleagues report a 27% uptake of influenza vaccine by pregnant women in three hospitals in New South Wales in 2011, with differences in uptake attributable to how the vaccine was promoted and the ease of accessing it.1 Influenza vaccination of pregnant women is an important issue that was highlighted during the 2009 pandemic. In Australia, the risk of hospitalisation with pandemic (H1N1) 2009 influenza for pregnant women compared with non-pregnant women aged 15–44 years was increased by about fivefold2 and the risk of admission to intensive care, by about sevenfold.3 The World Health Organization recently recommended influenza vaccination for pregnant women as the highest priority for countries considering initiation or expansion of programs for seasonal influenza vaccines.4

  • Heath A Kelly1
  • Nicholas Kelley2

  • 1 National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT.
  • 2 Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, Minn, USA.

Correspondence: heath.kelly@mh.org.au

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.